Evidence map›Paper›PMID 40328651›Full record

ArticleBMJ open2025

Clinical and cost-effectiveness of a personalised guided consultation versus usual physiotherapy care in people presenting with shoulder pain: a protocol for the PANDA-S cluster randomised controlled trial and process evaluation.

Sarah Harrisson, Helen Myers, Gwenllian Wynne-Jones, Ram Bajpai, Claire Bratt, Claire Burton, Rosie Harrison, Sue Jowett, Sarah Ann Lawton, Benjamin Saunders and 11 more

Abstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sarah HarrissonSchool of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK s.a.harrisson@keele.ac.uk.ORCID http://orcid.org/0000-0002-1304-3443
Helen MyersKeele Clinical Trials Unit, School of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.
Gwenllian Wynne-JonesSchool of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.ORCID http://orcid.org/0000-0002-0283-6632
Ram BajpaiSchool of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.ORCID http://orcid.org/0000-0002-1227-2703
Claire BrattKeele Clinical Trials Unit, School of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.
Claire BurtonSchool of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.ORCID http://orcid.org/0000-0003-4688-3075
Rosie HarrisonSchool of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.ORCID http://orcid.org/0000-0003-2292-5947
Sue JowettHealth Economics Unit, University of Birmingham, Birmingham, UK.
Sarah Ann LawtonKeele Clinical Trials Unit, School of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.ORCID http://orcid.org/0000-0002-8909-2057
Benjamin SaundersSchool of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.ORCID http://orcid.org/0000-0002-0856-1596
David BeardNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, England, UK.ORCID http://orcid.org/0000-0001-7884-6389
Milica BucknallSchool of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.
Rachel ChesterSchool of Health Sciences, Faculty of Medicine and Health, University of East Anglia, Norwich Research Park, Norwich, UK.
Carl HeneghanNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England, UK.ORCID http://orcid.org/0000-0002-1009-1992
Lucy HuckfieldMidlands Partnership University NHS Foundation Trust, Haywood Community Hospital, High Lane, Burslem, Stoke on Trent, Staffordshire, Stoke-On-Trent, UK.
Martyn LewisSchool of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.
Christian MallenSchool of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.
Tamar PincusSchool of Psychology, Highfield Campus, University of Southampton, Hampshire, UK.
J L ReesNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, England, UK.
Edward RoddySchool of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.
Danielle van der WindtSchool of Medicine, Faculty of Medicine & Health Sciences, Keele University, Keele, Staffordshire, UK.ORCID http://orcid.org/0000-0002-7248-6703

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMusculoskeletal shoulder pain is a common reason for people to be treated in physiotherapy services, but diagnosis can be difficult and often does not guide treatment or predict outcome. People with shoulder pain cite a need for clear information, and timely, tailored consultations for their pain. This trial will evaluate the introduction of a personalised guided consultation to help physiotherapists manage care for individuals with shoulder pain. METHODS AND ANALYSIS: This is a cluster randomised controlled trial to evaluate the clinical and cost-effectiveness of introducing a personalised guided consultation compared with usual UK NHS physiotherapy care. Physiotherapy services (n=16) will be randomised in a 1:1 ratio to either intervention (physiotherapy training package and personalised guided consultation incorporating a new prognostic tool) or control (usual care); 832 participants (416 in each arm) identified from participating physiotherapy service waiting lists aged 18 years or over with shoulder pain will be enrolled. Follow-up will occur at 3 time points: 6 weeks, 6 months and 12 months. The primary outcome will be the Shoulder Pain and Disability Index (SPADI) score over 12 months. Secondary outcomes include global perceived change of the shoulder condition, sleep, work absence and the impact of shoulder pain on work performance, healthcare utilisation and health-related quality of life (using EuroQol 5 Dimension 5 Level (EQ-5D-5L)). A multimethod process evaluation will investigate views and experiences of participants and physiotherapists, assess uptake, facilitators and barriers to delivery, and changes in factors assumed to explain intervention outcomes. Primary analysis of effectiveness will be by intention-to-treat, and a health economic evaluation will assess cost-utility of introducing the personalised consultation. ETHICS AND DISSEMINATION: The trial received ethics approval from the Yorkshire & The Humber (South Yorkshire) Research Ethics Committee (REC reference: 23/YH/0070). Findings will be shared through journal publications, media outlets and conference presentations. Supported by patient contributors and clinical advisors, we will communicate findings through a designated website, networks, newsletters, leaflets and in the participating physiotherapy services. TRIAL REGISTRATION NUMBER: ISRCTN45377604.

Indexed as

Physical Therapy ModalitiesPrecision MedicineReferral and ConsultationShoulder PainCost-Benefit AnalysisFemaleHumansQuality of LifeRandomized Controlled Trials as TopicUnited KingdomMusculoskeletal disordersPerson-Centered CarePragmatic Clinical TrialPrimary CareShoulder

Identifiers

PMID40328651
PMCPMC12056648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.